Search results for "myeloid leukemia cell"

showing 9 items of 9 documents

Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines

2018

Background: The antitumoral effects of different Toll-like receptor (TLRs) agonists is mediated by activating immune responses to suppress tumors growth, although TLR ligands may also have a direct effect on tumoral cells. Given that TLR signaling induces hematopoietic cell differentiations this may serve as a novel differentiation therapeutic approach for AML. Methods: We investigated the effects of agonists for the ten human TLRs on the proliferation, apoptosis, cell cycle and differentiation of ten different types of myeloid leukemia cell lines (HL-60, U-937, KG-1, KG-1a, K-562, Kasumi-1, EOL-1, NB4, MOLM-13 and HEL). Proliferation was measured using the CellTiter 96 (R) Aqueous One Solu…

0301 basic medicineCancer ResearchMyeloidImiquimodlcsh:RC254-282Flow cytometry03 medical and health sciences0302 clinical medicineToll-like receptorGeneticsmedicineCytotoxic T cellMyeloid leukemia cell lineslcsh:QH573-671Toll-like receptorImiquimodmedicine.diagnostic_testChemistryCell growthlcsh:CytologyMyeloid leukemiaCell cyclelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisCancer researchPrimary Researchmedicine.drugCancer Cell International
researchProduct

Antitumor Mechanism of the Essential Oils from Two Succulent Plants in Multidrug Resistance Leukemia Cell

2019

Drug resistance remains a major challenge in the treatment of cancer. The multiplicity of the drug resistance determinants raises the question about the optimal strategies to deal with them. Essential oils showed to inhibit the growth of different tumor cell types. Essential oils contain several chemical classes of compounds whose heterogeneity of active moieties can help prevent the development of drug resistance. In the present paper, we analyzed, by gas chromatography-mass spectrometry the chemical composition of the essential oil of the leaves of Kalanchoe beharensis obtained by hydrodistillation and compared the chemical composition of its essential oil with that of Cyphostemma juttae.…

<i>Kalanchoe beharensis</i>Celllcsh:Medicinelcsh:RS1-441Pharmaceutical ScienceKalanchoe beharensiDrug resistanceArticleessential oilNF-κBlaw.inventionlcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineKalanchoe beharensislawmultidrug resistanceCyphostemma juttaeDrug DiscoverymedicineNF-kappaBSettore BIO/15 - Biologia FarmaceuticaEssential oilacute myeloid leukemia cell030304 developmental biology0303 health sciences<i>Cyphostemma juttae</i>biologylcsh:RMyeloid leukemiaCyphostemma juttaebiology.organism_classificationmedicine.diseaseMultiple drug resistanceLeukemiamedicine.anatomical_structureBiochemistry030220 oncology & carcinogenesisSettore BIO/03 - Botanica Ambientale E ApplicataSettore BIO/14 - FarmacologiaMolecular MedicineKalanchoe beharensisPharmaceuticals
researchProduct

Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated me…

2010

Mutation of the Bcr–Abl oncoprotein is one of most frequent mechanisms by which chronic myelogenous leukemia (CML) cells become resistant to imatinib. Here, we show that treat- ment of cell lines harbouring wild type or mutant BCR–ABL with carboxyamidotriazole (CAI), a calcium influx and signal transduction inhibitor, inhibits cell growth, the expres- sion of Bcr–Abl and its downstream signalling, and induces apoptosis. Moreover, we show that CAI acts by increasing intracellular ROS. Clinically significant, CAI has also inhibitory effects on T315I Bcr–Abl mutant, a mutation that causes CML cells to become insensitive to imatinib and second generation abl kinase inhibitors.

Cancer Researchbcr-abl Carboxyamidotriazole chronic myeloid leukemia cells imatinibBlotting WesternFusion Proteins bcr-ablAntineoplastic AgentsApoptosisSignal transduction inhibitorBiologyPiperazineschemistry.chemical_compoundMicehemic and lymphatic diseasesCell Line TumorLeukemia Myelogenous Chronic BCR-ABL PositivemedicineAnimalsHumansneoplasmsCell ProliferationSettore MED/04 - Patologia GeneraleABLCarboxyamidotriazoleCell growthWild typeImatinibTriazolesmedicine.diseaseImatinib mesylatePyrimidinesOncologychemistryDrug Resistance NeoplasmBenzamidesMutationCancer researchImatinib MesylateReactive Oxygen SpeciesOxidation-ReductionChronic myelogenous leukemiamedicine.drug
researchProduct

Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives

2020

Abstract Well designed and safe nano drug carrier systems are an important tool in biomedical applications. The combination of two or more drugs has been used in medicine both to enhance the therapeutic effect and to decrease the side effects of drugs. Biocompatible halloysite nanotubes, that possess two different surfaces, are a suitable nanomaterial for a simultaneous carrier and release of two drugs that can exert a synergistic effect against cancer cells. In this study, three curcumin derivatives and doxorubicin were loaded by supramolecular and covalent linkage at the lumen and external surface of the halloysite nanotubes. The obtained multifunctional systems were characterized by seve…

Drugmedia_common.quotation_subjectNanoparticle020101 civil engineering02 engineering and technologyengineering.materialHalloysite0201 civil engineeringchemistry.chemical_compoundGeochemistry and PetrologymedicineDoxorubicinCytotoxicitymedia_commonSettore CHIM/02 - Chimica FisicaHalloysite nanotubes Curcumin derivatives Dual drug delivery Antiproliferative activity Breast cancer cell lines and acute myeloid leukemia cell linesChemistryGeologySettore CHIM/06 - Chimica Organica021001 nanoscience & nanotechnology3. Good healthCancer cellBiophysicsengineeringCurcuminSettore BIO/14 - Farmacologia0210 nano-technologyDrug carriermedicine.drug
researchProduct

Essential Oil Composition of

2019

Drug resistance is a major obstacle in antibiotic and antitumor chemotherapy. In response to the necessity to find new therapeutic strategies, plant secondary metabolites including essential oils (EOs) may represent one of the best sources. EOs in plants act as constitutive defenses against biotic and abiotic stress, and they play an important role in the pharmacology for their low toxicity, good pharmacokinetic and multitarget activity. In this context, natural products such as EOs are one of the most important sources of drugs used in pharmaceutical therapeutics. The aim of this paper was to identify the chemical composition of the essential oil of Alluaudia procera leaves, obtained by hy…

MagnoliopsidaMolecular StructureSpectrum AnalysisPhytochemicalsDrug ResistanceOils VolatileAntineoplastic AgentsArticleessential oilacute myeloid leukemia cellAnti-Bacterial AgentsDidiereaceaesucculent plantsMolecules (Basel, Switzerland)
researchProduct

EXOSOMES RELEASED BY K562 CHRONIC MYELOID LEUKEMIA CELLS PROMOTE ENDOTHELIAL CELL TUBULAR DIFFERENTIATION THROUGH UPTAKE AND CELL-TO-CELL TRANSFER

2011

Settore BIO/13 - Biologia ApplicataK562MYELOID LEUKEMIA CELLS
researchProduct

In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R

2021

Euphorbia species have a large spectrum of traditional medicinal uses. We tested the biological activities of the essential oil (EO) of Euphorbia intisy Drake in an acquired multidrug resistance leukemia model to assess whether the EO obtained by hydrodistillation of stems was able to reverse the resistant phenotype. HL-60R cell lines are characterized by the overexpression of P-glycoprotein (P-gp), inhibitors of apoptosis proteins (IAPs) and constitutive expression of NF-κB. EO chemical composition was determined by GC/MS analysis

lcsh:Medicinelcsh:RS1-441Pharmaceutical ScienceP-glycoprotein01 natural sciencesessential oilNF-κBFlow cytometrylcsh:Pharmacy and materia medicamultidrug resistanceDrug DiscoverymedicineChemosensitizing agentSettore BIO/15 - Biologia FarmaceuticaP-glycoproteincancer cellbiologymedicine.diagnostic_test010405 organic chemistryChemistrylcsh:RMyeloid leukemiamyeloid leukemia cellSettore CHIM/08 - Chimica FarmaceuticaMolecular biologyIn vitro0104 chemical sciencesMultiple drug resistance010404 medicinal & biomolecular chemistryApoptosisCell cultureSettore BIO/03 - Botanica Ambientale E ApplicataSettore BIO/14 - Farmacologiabiology.proteinMolecular Medicineinhibitors of apoptosis proteinsPharmaceuticals
researchProduct

Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models

2019

Drug resistance is a major obstacle in antibiotic and antitumor chemotherapy. In response to the necessity to find new therapeutic strategies, plant secondary metabolites including essential oils (EOs) may represent one of the best sources. EOs in plants act as constitutive defenses against biotic and abiotic stress, and they play an important role in the pharmacology for their low toxicity, good pharmacokinetic and multitarget activity. In this context, natural products such as EOs are one of the most important sources of drugs used in pharmaceutical therapeutics. The aim of this paper was to identify the chemical composition of the essential oil of Alluaudia procera leaves, obtained by hy…

medicine.drug_classAntibioticsPharmaceutical ScienceContext (language use)Drug resistancePharmacologyBiologymedicine.disease_causeSettore BIO/19 - Microbiologia Generaleessential oilAnalytical Chemistrylaw.inventionDidiereaceaelcsh:QD241-44103 medical and health scienceslcsh:Organic chemistryPharmacokineticslawDrug DiscoverymedicineSettore BIO/15 - Biologia FarmaceuticaPhysical and Theoretical ChemistryEssential oilacute myeloid leukemia cell030304 developmental biology0303 health sciences030306 microbiologyAbiotic stressOrganic ChemistryBiological activitySettore CHIM/06 - Chimica Organicasucculent plantsChemistry (miscellaneous)Staphylococcus aureusSettore BIO/03 - Botanica Ambientale E ApplicataSettore BIO/14 - FarmacologiaMolecular MedicineMolecules
researchProduct

Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia

2022

Drug resistance is the ability of cancer cells to gain resistance to both conventional and novel chemotherapy agents, and remains a major problem in cancer therapy. Resistance mechanisms are multifactorial and involve more strictly pharmacological factors, such as P-glycoprotein (P-gp) and biological factors such as inhibitor of apoptosis proteins (IAPs) and the nuclear factor-kappa B (NF-κB) pathway. Possible therapeutic strategies for the treatment of acute myeloid leukemia (AML) have increased in recent years; however, drug resistance remains a problem for most pa-tients. Phytol and heptacosane are the major compounds of Euphorbia intisy essential oil (EO) which were demonstrated to inhi…

phytolmultidrug resistanceP-gp inhibitorDrug DiscoveryP-glycoprotein; multidrug resistance; acute myeloid leukemia cell; P-gp inhibitors; phytol; heptacosaneheptacosaneSettore BIO/14 - FarmacologiaPharmaceutical ScienceMolecular MedicineP-glycoproteinSettore CHIM/08 - Chimica Farmaceuticaacute myeloid leukemia cell
researchProduct